See also this year's filing and all EDGAR filings for this company.
PDF Report 0001799191_2025_Oncology_Institute_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.17278589187022708, 'aggregate_val': 538681000, 'exp_sum': 651199000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 105574000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 538812000, 'DepreciationDepletionAndAmortization': 6944000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -131000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.2010323353504391, 'aggregate_val': 453530000, 'exp_sum': 567645000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 107828000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 453530000, 'DepreciationDepletionAndAmortization': 6287000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 0}} |
Graph
Absolute values for 0001799191, Oncology Institute Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 22,040,000 |
| 1 | AssetsNonCurrent | 26,371,000 |
| 2 | AssetsCurrent | 112,418,000 |
| 3 | PropertyPlantAndEquipment | 11,888,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 116,479,000 |
| 6 | LiabilitiesCurrent | 52,247,000 |
| 7 | remainder_Liabilities | 402,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 107,828,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 453,530,000 |
| 13 | DepreciationDepletionAndAmortization | 6,287,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -114,115,000 |
| 17 | remainder_Revenues | 393,412,000 |
| 18 | remainder_NetIncome | -4,545,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 172,717,000 |
| 1 | Liabilities | 169,128,000 |
| 2 | Expenses | 453,530,000 |
| 3 | Revenues | 393,412,000 |
| 4 | StockholdersEquity | 3,589,000 |
| 5 | NetIncome | -64,663,000 |
| 6 | ComprehensiveNetIncome | -64,663,000 |
| 7 | BaseVar | 596,666,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.348 |
| 9 | EconomicCapitalRatio | 0.853 |